During the three-day exhibition of WHX Dubai (WHX2026) in Dubai, TGS achieved measurable milestones in its regional expansion strategy within the field of infection control.
More than 100 product presentation request forms were received from MENA and GCC countries, and over 12 structured B2B meetings were conducted with distributors, healthcare procurement leaders, and industry stakeholders.
WHX2026, recognized as one of the region’s leading healthcare exhibitions, provided a strategic platform for TGS to strengthen its export-driven roadmap and accelerate market access across the GCC and broader MENA region.
Strategic Objectives at WHX2026
TGS participated with a focused agenda:
Expanding regional market access in infection control
Engaging hospital procurement leaders and regional distributors
Showcasing its hospital-grade disinfectant portfolio (hand, skin, surface, and instrument solutions)
Exploring Private Label and Contract Manufacturing partnerships
Key Outcomes
Over the course of WHX2026 in Dubai:
100+ qualified product presentation requests from regional stakeholders
12+ high-level B2B meetings
Strategic negotiations initiated with major manufacturers for private label production of selected TGS-developed solutions
These outcomes demonstrate strong regional demand for structured, hospital-grade infection control solutions.
Introduction of AXIA INNOVA as Regional Market Access Partner
As part of its international growth strategy, TGS formally introduced AXIA INNOVA Sterilizers & Disinfectants Trading LLC as its commercial, regulatory, and market access partner in Dubai.
AXIA INNOVA supports selected TGS-developed solutions through distribution development, regulatory alignment, and structured regional expansion across GCC and international markets.
A Structured Expansion Strategy
TGS’ presence at WHX2026 Dubai reflects a long-term strategy focused on:
Regulatory-aligned market entry
Regional commercial partnerships
Private label collaboration models
Sustainable distributor network development
TGS continues to position itself as a reliable provider of hospital-grade infection control solutions across regional and international markets.
For partnership inquiries, distributors and healthcare groups may contact TGS or AXIA INNOVA for further engagement.
